MetaADEDB 2.0 @ LMMD
thyroxine, triiodothyronine drug combination
(LKYWLLWWYBVUPP-XOCLESOZSA-L)
Structure
SMILES
[O-]C(=O)[C@H](Cc1cc(I)c(c(c1)I)Oc1cc(I)c(c(c1)I)O)N.[O-]C(=O)[C@H](Cc1cc(I)c(c(c1)I)Oc1ccc(c(c1)I)O)N.[Na+].[Na+]
Type(s)
Approved
Molecular Formula:
C30H21I7N2Na2O8
Molecular Weight:
1471.810
Log P:
7.2412
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
4
TPSA:
191.22
CAS Number(s):
8065-29-0
Synonym(s)
1.
thyroxine, triiodothyronine drug combination
2.
Euthroid
3.
Euthyral
4.
Thyreotom
5.
Thyrolar
6.
liotrix
7.
thyroxine - triiodothyronine combination
8.
thyroxine - triiodothyronine combination, monosodium salt
9.
triiodothyronine - thyroxine combination
External Link(s)
MeSHD013974
C018539
PubChem Compound138402339
71371
ChEBI6485
DrugBankDB01583
KEGGdr:D00361
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 2US FAERS
2PalpitationsFAERS: 2US FAERS
3AgitationFAERS: 1US FAERS
4AstheniaFAERS: 1US FAERS
5Atrial FlutterFAERS: 1US FAERS
6Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
7Cardiac ArrestFAERS: 1US FAERS
8Drug withdrawal syndromeFAERS: 1US FAERS
9HypersomniaFAERS: 1US FAERS
10NervousnessFAERS: 1US FAERS
11Pharmaceutical product complaintFAERS: 1US FAERS
12Product substitution issueFAERS: 1US FAERS
13Temperature intoleranceFAERS: 1US FAERS
14TremorFAERS: 1US FAERS
15Unevaluable eventFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.